Source link : https://newshealth.biz/health-news/up-to-40-of-diabetes-patients-achieved-normal-hba1c-with-retatrutide/
NEW ORLEANS — Monotherapy with once-weekly retatrutide, an investigational triple hormone receptor agonist, improved glycemic control and body weight in adults with type 2 diabetes, the phase III TRANSCEND-T2D-1 trial showed. Among 537 adults, average change from baseline in HbA1c concentration was -1.69% with retatrutide 4 mg, -1.86% with 9 mg, and -1.94% with 12 […]
The post Up to 40% of Diabetes Patients Achieved Normal HbA1c With Retatrutide first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-07 20:18:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8